Bevacizumab and Paclitaxel
About
Membership operator: AND
Therapies: 2
Therapies
Bevacizumab (tx:ncit:C2039)
Paclitaxel (tx:ncit:C1411)
Therapeutic response
Precision oncology relationships for therapeutic response involving this therapy group.
Organizations
Biomarkers
Cancer types
Therapies
| Organizations | Biomarkers | Cancer types | Therapies | |
|---|---|---|---|---|
| HSE (1) | HER2-negative | Invasive Breast Carcinoma | Bevacizumab, Paclitaxel |